PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-38.37%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-62.05%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-71.04%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-71.04%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-69.69%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-69.70%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-69.64%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
-0.13%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.33%
Dividend growth of 0.33% while AR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-33.19%
Negative OCF growth while AR is at 7.56%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-73.31%
Negative FCF growth while AR is at 15.38%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
415.69%
10Y revenue/share CAGR above 1.5x AR's 226.56%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
344.68%
5Y revenue/share CAGR above 1.5x AR's 76.73%. David Dodd would look for consistent product or market expansions fueling outperformance.
161.95%
Positive 3Y CAGR while AR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
438.64%
10Y OCF/share CAGR above 1.5x AR's 83.73%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
372.62%
5Y OCF/share CAGR 1.25-1.5x AR's 266.41%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
-21.13%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
1378.39%
Net income/share CAGR above 1.5x AR's 196.15% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
417.65%
5Y net income/share CAGR above 1.5x AR's 129.17%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-39.82%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
518.48%
10Y equity/share CAGR above 1.5x AR's 24.95%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
246.88%
5Y equity/share CAGR above 1.5x AR's 2.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
89.84%
3Y equity/share CAGR above 1.5x AR's 31.02%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
2016.49%
10Y dividend/share CAGR above 1.5x AR's 12.12%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
5483.84%
Dividend/share CAGR of 5483.84% while AR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
518.27%
3Y dividend/share CAGR of 518.27% while AR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-23.94%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-59.38%
Inventory is declining while AR stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.43%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-2.83%
We have a declining book value while AR shows 1.35%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
22.83%
We have some new debt while AR reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
311.11%
SG&A growth well above AR's 24.05%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.